The retail pharmacy will stock Auvi-Q, an epinephrine auto-injector manufactured by Kaleo, which was previously only available through its mail delivery program.
The list price for Auvi-Q is steep at $4,500; however, a spokesperson for the company said eligible patients with commercial insurance, including those with high deductible health plans or whose insurers don’t cover it, can get Auvi-Q for free.
Those who pay cash at the pharmacy counter will be charged $360 for two auto-injectors.
Auvi-Q’s introduction into Walgreens retail pharmacy comes as the nation faces a shortage of EpiPens sparked by manufacturing delays. Drugstores across the U.S. have run short on supply, and families have been scrambling to find EpiPens during the back-to-school season.
More articles on supply chain:
Data accuracy, clinical integration & more: 3 takeaways from AHRMM’s Supply Chain Conference
Kaiser changes EpiPen prescription policy after complaints
A drug to treat hemophilia, Non-Hodgkin lymphoma & more: 4 latest FDA approvals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
